The Inflammasome Therapeutics Summit is a leading global conference dedicated to advances in inflammasome research and drug development. Shaperon’s participation and keynote presentation underscore ...

The inflammasome, a multiprotein complex, plays a crucial role in the field of innate immunity. It is activated by pathogen-associated molecular patterns (PAMPs) or damage-associated molecular ...

Brenig has launched an early Phase 1 trial to evaluate BT-409, its experimental small molecule therapy, in healthy volunteers ...

NEWTON, Mass.--(BUSINESS WIRE)--Inflammasome Therapeutics (https://www.inflam.com), is a clinical-stage biotech company developing a new class of inflammasome inhibitors called Kamuvudines for ...

Advances in inflammasome biology are helping researchers address key selectivity and safety challenges in drug development.